PATRIARCA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 516
NA - Nord America 146
AS - Asia 71
OC - Oceania 3
SA - Sud America 2
AF - Africa 1
Totale 739
Nazione #
DE - Germania 397
US - Stati Uniti d'America 142
IT - Italia 50
CN - Cina 29
SE - Svezia 25
IN - India 18
GB - Regno Unito 16
IE - Irlanda 12
JP - Giappone 10
TW - Taiwan 6
FR - Francia 5
CA - Canada 4
AU - Australia 3
ES - Italia 2
ID - Indonesia 2
KR - Corea 2
NL - Olanda 2
TR - Turchia 2
UA - Ucraina 2
AR - Argentina 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
IL - Israele 1
LK - Sri Lanka 1
PT - Portogallo 1
SC - Seychelles 1
SI - Slovenia 1
Totale 739
Città #
Hanover 235
Frankfurt am Main 153
Chandler 36
Milan 19
New York 14
Ashburn 13
Dublin 12
Princeton 12
Southend 11
Beijing 6
Bengaluru 5
Berlin 4
Des Moines 4
Meguro-ku 4
Naples 4
Fairfield 3
Bologna 2
Bonate Sopra 2
Cambridge 2
Chicago 2
Guangzhou 2
Istanbul 2
Melbourne 2
Münster 2
New Taipei 2
Rome 2
Seattle 2
Seoul 2
Taichung 2
Taipei 2
Tokyo 2
Toronto 2
Victoria 2
Athens 1
Beersheba 1
Bern 1
Bühl 1
Ceska Ves 1
Chennai 1
City of Westminster 1
Cleveland 1
Colombo 1
Esslingen am Neckar 1
Florence 1
Frederick 1
Fremont 1
Garbagnate Milanese 1
Genoa 1
Haarlem 1
Houston 1
Jinan 1
Lisbon 1
Ljubljana 1
London 1
Los Angeles 1
Madrid 1
Mahé 1
Mulazzano 1
Odense 1
Phoenix 1
Provin 1
Rho 1
San Giuliano Milanese 1
São Paulo 1
Taiyuan 1
Zwolle 1
Totale 602
Nome #
Evidence based use of erytrhopoietin in patients with autoimmune hemolytic anemia: a multicenter international study 287
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 114
Evans syndrome in adults : an observational multicenter study 95
Evidence based use of erytrhopoietin in patients with Autoimmune Hemolytic Anemia : a multicenter international study 78
Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome 66
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera 64
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib 59
Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network 1
Totale 764
Categoria #
all - tutte 1.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 2 2 3 0 3 2 8 10 6 0 2
2021/2022320 0 3 10 31 36 36 33 46 48 36 23 18
2022/2023162 17 14 18 11 19 21 1 19 27 5 8 2
2023/2024244 4 9 6 4 26 24 53 44 23 45 6 0
Totale 764